Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Fimmic Raises

publication date: Dec 22, 2017
 | 
author/source: Fimmic

Fimmic, a Finnish medtech company developing Deep Learning AI solutions for digital medical microscopy, announced today that it has closed a €5M investment round to accelerate scaling of its WebMicroscope® AI Cloud for tissue diagnostics.

FimmicLed by new investor Ascend Capital Partners, the round brings the Company’s total raised funds in 2017 to €6.6M. Existing investors, including ACME Investments and STO-Rahoitus, also participated this round. 

Fimmic’s WebMicroscope is the first commercial platform that supports pathologists and medical researchers in tissue diagnostics through deep learning AI-based image analysis. 

WebMicroscope aims to improve the speed and accuracy of diagnosis which translates into more precise and personalized patient care. Fimmic’s WebMicroscope was recently nominated as the winner of the Innovation Award for Artificial Intelligence-based Digital Pathology Solution by Frost & Sullivan. 

“Our AI algorithms have been successfully used in various applications ranging from cancer research to drug development projects on Parkinson’s disease and liver diseases,” says Kaisa Helminen, CEO of Fimmic. “The results are extremely promising and our technology has received great interest from various industries and application areas. With this investment we are now able to grow the team, expand our marketing actions and launch our local activities in the US market,” she concludes.

“Artificial Intelligence (AI) holds great potential in several fields of medicine, including tissue diagnostics,” says Monita Mo, CEO of Ascend Capital Partners. “We were impressed about the expertise in the Fimmic team and their proven track record in executing development plans for a commercial product. We are excited to offer our experience and contact network to support Fimmic in their global expansion.” 

Fimmic, founded in 2013, is a spin-off company from the Finnish Institute for Molecular Medicine at the University of Helsinki. The next-generation WebMicroscope AI Platform was launched in spring 2017 and has since been used in a wide range of image analysis applications globally.


more about fimmic


 



 

News Channels

 

 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 

 

 

 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events